Analysis of Neural Subtypes Reveals Selective Mitochondrial Dysfunction in Dopaminergic Neurons from Parkin Mutants
Overview
Affiliations
Studies of the familial Parkinson disease-related proteins PINK1 and Parkin have demonstrated that these factors promote the fragmentation and turnover of mitochondria following treatment of cultured cells with mitochondrial depolarizing agents. Whether PINK1 or Parkin influence mitochondrial quality control under normal physiological conditions in dopaminergic neurons, a principal cell type that degenerates in Parkinson disease, remains unclear. To address this matter, we developed a method to purify and characterize neural subtypes of interest from the adult Drosophila brain. Using this method, we find that dopaminergic neurons from Drosophila parkin mutants accumulate enlarged, depolarized mitochondria, and that genetic perturbations that promote mitochondrial fragmentation and turnover rescue the mitochondrial depolarization and neurodegenerative phenotypes of parkin mutants. In contrast, cholinergic neurons from parkin mutants accumulate enlarged depolarized mitochondria to a lesser extent than dopaminergic neurons, suggesting that a higher rate of mitochondrial damage, or a deficiency in alternative mechanisms to repair or eliminate damaged mitochondria explains the selective vulnerability of dopaminergic neurons in Parkinson disease. Our study validates key tenets of the model that PINK1 and Parkin promote the fragmentation and turnover of depolarized mitochondria in dopaminergic neurons. Moreover, our neural purification method provides a foundation to further explore the pathogenesis of Parkinson disease, and to address other neurobiological questions requiring the analysis of defined neural cell types.
miR-124 coordinates metabolic regulators acting at early stages of human neurogenesis.
Son G, Na Y, Kim Y, Son J, Clemenson G, Schafer S Commun Biol. 2024; 7(1):1393.
PMID: 39455851 PMC: 11511827. DOI: 10.1038/s42003-024-07089-2.
Stauch K, Totusek S, Trease A, Estrella L, Emanuel K, Fangmeier A Sci Rep. 2023; 13(1):11414.
PMID: 37452120 PMC: 10349111. DOI: 10.1038/s41598-023-38484-0.
The compartmentalised nature of neuronal mitophagy: molecular insights and implications.
Borbolis F, Palikaras K Expert Rev Mol Med. 2022; 24:e38.
PMID: 36172898 PMC: 9884780. DOI: 10.1017/erm.2022.31.
Nicotine Has a Therapeutic Window of Effectiveness in a Model of Parkinson's Disease.
Mannett B, Capt B, Pearman K, Buhlman L, VandenBrooks J, Call G Parkinsons Dis. 2022; 2022:9291077.
PMID: 35844833 PMC: 9286976. DOI: 10.1155/2022/9291077.
Lee S, Park S, Yeo S, Kwon O, Lee M, Yoo H Diagnostics (Basel). 2022; 12(1).
PMID: 35054279 PMC: 8774435. DOI: 10.3390/diagnostics12010112.